Back to cover

The International Finance Corporation’s Investments in the Pharmaceutical and Life Sciences Sector

Bibliography

Caris Life Sciences. “Difference Between Small Molecule and Large Molecule Drugs.” https://www.carislifesciences.com/difference-between-small-molecule-and-large-molecule-drugs.

Economist Intelligence Unit. 2023. Healthcare and Pharmaceuticals. World Industry Outlook. Economist Intelligence Unit.

GPCA (Global Private Capital Association). 2023. “2023 GPCA Industry Data and Analysis.” February 21, 2023. https://www.globalprivatecapital.org/research/2023-global-private-capital-industry-data.

IFC (International Finance Corporation). 2021. “Inside Africa’s Push to Make Its Own Medicines.” News, IFC. https://www.ifc.org/en/stories/2021/africa-pharma-manufacturing-hubs-en#:~:text=In%20most%20nations%20of%20sub,vulnerable%20to%20supply%20chain%20disruptions.

Jonnston, Ian, and Amy Borrett. 2024. “The World’s Broken Market for Medicines.” Financial Times, March 28, 2024. https://www.ft.com/content/6143300d-d11a-4b2f-898c-87c5dd0ff6ce.

Scott, Jeffrey A., Jochen Lennerz, Melissa Lynne Johnson, et al. 2024. “Compromised Outcomes in Stage IV Non–Small-Cell Lung Cancer with Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data.” JCO Oncology Practice 20 (1): 125–53. https://doi.org/10.1200/OP.22.0061.

USFDA (US Food and Drug Administration). n.d. “Generic Drugs: Questions and Answers.” FDA.gov. https://www.fda.gov/drugs/frequently-asked-questions-popular-topics/generic-drugs-questions-answers#q1